癌症研究档案

  • 国际标准期刊号: 2254-6081
  • 期刊 h 指数: 13
  • 期刊引用分数: 3.58
  • 期刊影响因子: 3.12
索引于
  • 中国知网(CNKI)
  • 引用因子
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

The utilization of lung cancer screenings in relation to lung cancer risk and comorbidity

Ronald Ching

This study evaluated a distinct kind of antibody that is on little animate thing vesicles (sEVs), as a biomarker for early detection of carcinoma. The sEVs were isolated from plasma by centrifugation and valid with morphology and typical markers. The antibody levels were quantified by enzyme-linked immunosorbent assay, and more analysis indicated that the antibody panel on sEVs was higher than that from humour to differentiate benign respiratory organ illness (n = 32) from carcinoma (n = 90). Within the prospective study, antibody on sEVs performed higher in identification of patients with a better risk of carcinoma. What is more, with immunogold labeling transmission microscopy, Nanoflow cytometry and binding tests, we tend to illustrated that the autoantibodies may bind to the antigens on sEVs, which can justify the detected autoantibodies on sEVs. Besides, the binding resulted within the attenuation of complement-mediated toxicity, which can contribute to the immune escape of carcinoma.

Keywords: Lung cancer; tumor; Sarcoma; Carcinoma research

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证